MNKD FY 2023 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$199M+99.4% YoY

Gross Profit

$136M68.5% margin

Operating Income

$9M4.4% margin

Net Income

-$12M-6.0% margin

EPS (Diluted)

$-0.04

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

-$8M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$475M

Total Liabilities

$721M

Stockholders' Equity

-$246M

Cash & Equivalents

$238M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$199M	$100M	+99.4%
Gross Profit	$136M	$42M	+222.2%
Operating Income	$9M	-$64M	+113.5%
Net Income	-$12M	-$87M	+86.3%